Skip to content

Oragenics, Inc.

OGEN

CIK 0001174940

← back to feed
Revenue (TTM)
$123.7K
−71.4% YoY Q1 May 2026
Net Income (TTM)
−$9.76M
+6.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$9.22
+90.5% YoY Q1 May 2026
Gross Margin
139.3%
Q1 May 2026
Operating Margin
-7,372.8%
Q1 May 2026
Net Margin
-7,887.5%
Q1 May 2026
Free Cash Flow (TTM)
−$9.61M
Q1 May 2026
Cash
$6.11M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
4.51M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings